Sanara MedTech financials
$35.09−0.03%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $28.1M | $27.8M | $27.5M | $26.3M | $25.8M | $23.4M | $26.3M | $21.7M | $20.2M | $18.5M | $17.7M | $16.0M |
| Gross profit | $26.2M | $25.9M | $25.7M | $24.5M | $23.9M | $21.6M | $24.1M | $19.7M | $18.2M | $16.6M | $15.9M | $14.3M |
| Gross margin | 93.0% | 93.1% | 93.2% | 92.9% | 92.5% | 92.2% | 91.4% | 90.8% | 90.0% | 89.8% | 89.9% | 89.1% |
| Operating income | $1.8M | $2.6M | $1.1M | $2.9M | $2.5M | $825.5K | $2.3M | $778.5K | -$2.9M | -$1.5M | -$226.0K | -$906.7K |
| Net income | -$452.9K | $459.0K | -$1.6M | -$30.4M | -$2.0M | -$3.5M | -$1.5M | -$2.9M | -$3.5M | -$1.8M | -$237.2K | -$1.1M |
| Net margin | −1.6% | 1.7% | −5.8% | −115.5% | −7.8% | −15.1% | −5.8% | −13.2% | −17.4% | −9.5% | −1.3% | −6.6% |
| Diluted EPS | $-0.05 | $0.05 | $-0.20 | $-3.40 | $-0.23 | $-0.41 | $-0.18 | $-0.34 | $-0.41 | $-0.21 | $-0.03 | $-0.13 |
| EBITDA | $2.4M | $3.2M | $3.6M | $4.0M | $3.6M | $1.9M | $3.9M | $1.9M | -$1.8M | -$492.0K | -$2.6M | $91.0K |
| Operating cash flow | $2.0M | -$2.5M | $3.9M | $2.2M | $2.7M | -$2.0M | $932.0K | $2.1M | -$1.4M | -$1.6M | -$848.5K | $1.1M |
| Free cash flow | $2.0M | -$2.5M | $3.9M | $1.1M | $902.7K | -$3.7M | $859.9K | $2.0M | -$1.5M | -$1.7M | -$902.8K | $893.8K |
| Diluted shares | 8.7M | 9.0M | 8.1M | 8.9M | 8.9M | 8.6M | 8.5M | 8.5M | 8.5M | 8.4M | 8.4M | 8.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $15.4M | $13.6M | $16.6M | $14.9M | $17.0M | $20.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $47.0M | $46.8M | $46.5M | $45.6M | $45.3M | $44.6M |
| Total assets | $69.1M | $69.3M | $72.9M | $71.1M | $98.8M | $96.4M |
| Total liabilities | $61.2M | $62.3M | $67.0M | $64.9M | $63.4M | $59.7M |
| Shareholders' equity | $7.9M | $7.0M | $5.9M | $6.1M | $35.4M | $36.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology